![](/img/cover-not-exists.png)
Tumor dihydropyrimidine dehydrogenase in stage II and III colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone
Takashi Tsuji, Terumitsu Sawai, Hiroaki Takeshita, Tohru Nakagoe, Shigekazu Hidaka, Atsushi Nanashima, Hiroyuki Yamaguchi, Toru Yasutake, Takeshi Nagayasu, Yutaka TagawaVolume:
204
Year:
2004
Language:
english
Pages:
105
DOI:
10.1016/j.canlet.2003.09.030
File:
PDF, 130 KB
english, 2004